More than a third (36%) of myeloma (ICD-10 C88-C90 including malignant immunoproliferative diseases) cases in England are diagnosed following a routine or urgent GP referral (but not under the ‘two-week wait’ referral route).
A third (33%) of myeloma cases in England are diagnosed after presenting as an emergency. More than 6 in 11 (62%) of emergency presentation cases are via Accident and Emergency (A&E), with the other cases coming via an emergency GP referral, inpatient referral or outpatient referral.
More than 3 in 20 (17%) of myeloma cases in England are diagnosed via the ‘two-week wait’ referral route. This proportion is low compared with the average across all cancer types.
There are variations in routes to diagnosis by sex, age, deprivation and ethnicity.
Myeloma (C88-C90), Percentage of Cases by Route to Diagnosis, Adults Aged 15-99, England, 2012-2013
- National Cancer Intelligence Network. Routes to diagnosis 2006-2013 workbook (a). London: NCIN; 2015
- National Cancer Intelligence Network. Routes to diagnosis 2006-2013 workbook (b). London: NCIN; 2016.
- National Cancer Intelligence Network. Routes to diagnosis Site Specific Data Briefings 2006-2013. London: NCIN; 2016.
About this data
Data is for: England, 2012-2013, ICD-10 C88-C90
Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2012-2013. Staging proportions only include patients with a known stage (cases with an unknown stage at diagnosis are not included in the denominator).